Literature DB >> 35857681

Treatment Inequity: Examining the Influence of Non-Hispanic Black Race and Ethnicity on Pancreatic Cancer Care and Survival in Wisconsin.

Andrea M Schiefelbein1, John K Krebsbach2, Amy K Taylor3,2, Jienian Zhang4, Chloe E Haimson4, Amy Trentham-Dietz2,5, Melissa C Skala1,2,6, John M Eason4,2,7,8, Sharon M Weber2, Patrick R Varley2,9, Syed N Zafar2,9, Noelle K LoConte10,5.   

Abstract

INTRODUCTION: We investigated race and ethnicity-based disparities in first course treatment and overall survival among Wisconsin pancreatic cancer patients.
METHODS: We identified adults diagnosed with pancreatic adenocarcinoma in the Wisconsin Cancer Reporting System from 2004 through 2017. We assessed race and ethnicity-based disparities in first course of treatment via adjusted logistic regression and overall survival via 4 incremental Cox proportional hazards regression models.
RESULTS: The study included 8,490 patients: 91.3% (n = 7,755) non-Hispanic White; 5.1% (n = 437) non-Hispanic Black, 1.8% (n = 151) Hispanic, 0.6% Native American (n = 53), and 0.6% Asian (n = 51) race and ethnicities. Non-Hispanic Black patients had lower odds of treatment than non-Hispanic White patients for full patient (OR, 0.52; 95% CI, 0.41-0.65) and Medicare cohorts (OR, 0.40; 95% CI, 0.29-0.55). Non-Hispanic Black patients had lower odds of receiving surgery than non-Hispanic White patients (full cohort OR, 0.67 [95% CI, 0.48-0.92]; Medicare cohort OR, 0.57 [95% CI, 0.34-0.93]). Non-Hispanic Black patients experienced worse survival than non-Hispanic White patients in the first 2 incremental Cox proportional hazard regression models (model II HR, 1.18; 95% CI, 1.06-1.31). After adding insurance and treatment course, non-Hispanic Black and non-Hispanic White patients experienced similar survival (HR, 0.98; 95% CI, 0.88-1.09).
CONCLUSION: Non-Hispanic Black patients were almost 50% less likely to receive any treatment and 33% less likely to receive surgery than non-Hispanic White patients. After including treatment course, non-Hispanic Black and non-Hispanic White patient survival was similar. Increasing non-Hispanic Black patient treatment rates by addressing structural factors affecting treatment availability and employing culturally humble approaches to treatment discussions may mitigate these disparities. Copyright© Board of Regents of the University of Wisconsin System and The Medical College of Wisconsin, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35857681      PMCID: PMC9354557     

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  40 in total

1.  Opioid Prescribing by Specialty and Volume in the U.S.

Authors:  Gery P Guy; Kun Zhang
Journal:  Am J Prev Med       Date:  2018-09-12       Impact factor: 5.043

2.  Racial differences in primary care opioid risk reduction strategies.

Authors:  William C Becker; Joanna L Starrels; Moonseong Heo; Xuan Li; Mark G Weiner; Barbara J Turner
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

3.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

4.  Limited English proficient Hmong- and Spanish-speaking patients' perceptions of the quality of interpreter services.

Authors:  Maichou Lor; Phia Xiong; Rebecca J Schwei; Barbara J Bowers; Elizabeth A Jacobs
Journal:  Int J Nurs Stud       Date:  2015-04-03       Impact factor: 5.837

5.  Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation.

Authors:  J Kirkegård; E K Aahlin; M Al-Saiddi; S O Bratlie; M Coolsen; R J de Haas; M den Dulk; C Fristrup; E M Harrison; M B Mortensen; M W Nijkamp; J Persson; J A Søreide; S J Wigmore; T Wik; F V Mortensen
Journal:  Br J Surg       Date:  2019-03-04       Impact factor: 6.939

6.  Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.

Authors:  Taylor S Riall; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

7.  Annual report to the nation on the status of cancer, part I: National cancer statistics.

Authors:  S Jane Henley; Elizabeth M Ward; Susan Scott; Jiemin Ma; Robert N Anderson; Albert U Firth; Cheryll C Thomas; Farhad Islami; Hannah K Weir; Denise Riedel Lewis; Recinda L Sherman; Manxia Wu; Vicki B Benard; Lisa C Richardson; Ahmedin Jemal; Kathleen Cronin; Betsy A Kohler
Journal:  Cancer       Date:  2020-03-12       Impact factor: 6.921

8.  Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.

Authors:  Ryan Nipp; Angela C Tramontano; Chung Yin Kong; Pari Pandharipande; Emily C Dowling; Deborah Schrag; Chin Hur
Journal:  Cancer Med       Date:  2018-01-11       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.